IL1B and neoplasm: Proteins that stimulate the secretion of RANKL by osteoblasts, such as PTHrP, IL-1, TGF-β, and PDGF, inhibit the abnormal RANKL expression by osteoblasts in the tumor microenvironment (Rahman et al., 2015; Fukawa et al., 2022).